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We have recently demonstrated induction of expres-
sion of several members of the fibroblast growth factor 
family during wound healing, particularly for kerati-
nocyte growth factor, which was more than iSO-fold 
induced within 24 h after injury. To assess whether 
wound-healing disorders are associated with a defect in 
fibroblast growth factor regulation, we have now in-
vestigated the expression of these mitogens as well as 
their receptors in normal and wounded skin of geneti-
cally diabetic db/db mice, which are characterized by 
their impaired wound healing. We demonstrate that 
induction ofkeratinocyte growth factor expression in 
these mice is significantly reduced and delayed com-
pared to normal mice. Induction of acidic fibroblast 
growth factor (FGF) and basic FGF expression was ear-
C utaneous injury is characterized by fibroplasia, angio-genesis, and re-epithelialization and involves the mi-gration and proliferation of cells such as fibroblasts, endothelial cells, and epithelial cells [1]. The homo-zygous genetically diabetic (db/db) mouse develops 
obesity, insulin resistance, and severe hyperglycemia resembling 
adult onset diabetes mellitus [2]. Wound healing in db/db mice is 
markedly delayed, but can be reversed by the topical application of 
growth factors such as platelet-derived growth factor and several 
members of the fibroblast growth factor family [3 - 5]. These studies 
suggest that the corresponding endogenous growth factors are es-
sential for normal wound repair and might be limited during tissue 
repair in diabetic animals. 
The fibroblast growth factor family comprises at least nine differ-
ent rnitogens including acidic fibroblast growth factor (aFGF) [6], 
basic FGF (bFGF) [7], FGF-3 (int-2) [8], FGF-4 (hst) [9], FGF-5 
[10]. FGF-6 [11], keratinocyte growth factor (KGF, FGF-7) [12], 
androgen-induced growth factor (FGF-8) [13], and glia-activating 
factor (FGF-9) [14] . They stimulate mitogenesis and chemotaxis for 
a -wide variety of cell types both of mesenchymal and epithelial 
origin and therefore have the properties expected of wound cyto-
kines. We have recently studied the expression of FGFs and their 
receptors during the healing of full-thickness wounds in normal 
mice [15] . We found significant induction of several members of 
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lier in diabetic mice than in normal mice, but by 3 d 
after injury expression of these mitogens had already 
returned to the basal levels. In contrast, elevated levels 
of acidic FGF and basic FGF transcripts were detected 
within the first S d in wounds from normal mice. Thus, 
FGFs seem to be expressed in a limited fashion in the 
wound tissue of db/db mice during the period when 
re-epithelialization and granulation tissue formation 
normally occur. These findings provide an explana-
tion for the beneficial effect of exogenous FGF in the 
treatment of impaired wound healing in these animals 
and suggest that induction ofKGF early in repair may 
be critical for the rapid re-epithelialization in normal 
wound healing. Key words: dermis/epiJermis/jibrobltUt 
growth factorreceptor. ] Invest Dermatol1 03 :469 - 473, 1994 
the FGF family within a few hours after injury. This effect was 
particularly dramatic for keratinocyte growth factor (KGF), which 
was 160-fold induced within 24 h after wounding. KGF made by 
cells at the wound edge and below the wound, possibly by fibro-
blasts [15] , is a potent and specific growth factor for epithelial cells 
[12,16] . This suggests that dermally derived KGF stimulates migra-
tion and proliferation of keratinocytes during wound healing in a 
paracrine fashion. To determine whether the observed induction of 
KGF is indeed biologically important for normal repair, we studied 
the expression of KGF and other FGFs during the delayed wound 
healing of db/db mice. Our findings indicate that FGFs or other 
growth factors with similar function are limited during wound 
healing in these animals. The data provide a possible explanation for 
the beneficial role of exogenous FGF in wound repair and suggest 
that aberrant expression of endogenous FGFs might underlie the 
delayed wound healing in diabetic animals. 
MATERIALS AND METHODS 
Animals C57BL/KsJ-db/m mice obtained from Jackson Laboratories 
(Bar Harbor. ME) were chosen because they exhibit characteristics similar to 
those of human adult onset diabetes as a result of a single autosomal recessive 
mutation on chromosome 4. Only the homozygous animals develop dia-
betes [2]. The animals were 8-12 weeks of age at the start of the experi-
ments. Animals were housed one per cage. and maintained in a central 
animal facility with a 12-h light/dark cycle. The animal care facility was 
maintained by professionals who followed federal guidelines, and all proce-
dures were approved by the Institutional Animal Care Utilization Commit-
tee. 
Wounding and Preparation of Wound Tissue Three independent 
wound-healing experiments were performed. For every experiment twenty-
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Figure 1. Reduced and delayed expression of KGF mRNA during 
wound healing in db/db mice. Total cellular RNA (50 Ilg) from non-
wounded and wounded back skin of db/db mice was analyzed by RNAse 
protection assay with an RNA hybridization probe complementary to 
mRNA encoding murine KGF. Hybridization was performed under high-
stringency conditions to avoid cross-hybridizations with other FGF 
mRNAs. The gel was exposed for 8 h. The time after injury is indicated On 
top of each lane. The KGF expression in non-wounded skin of db/db mice is 
shown in the lane labeled "normal skin." The same RNA preparations were 
used for all hybridizations of Figs 1, 3, and 4. Fifty micrograms of tRNA 
were used as a negative control. 1000 cpm of the hybridization probe was 
added to the lane labeled "probe." 
three animals were anesthesized under methoxyflurane (Metofane, Priman-
Moore, Inc). The animals' backs were shaved and wiped with 30% isopropyl 
alcohol, and six full-thickness wounds (6 mm diameter, 3-4 mm apart) 
were made on 20 mice per experiment by excising the skin and palltJiw!us 
COrtlosus. The wounds were allowed to dry to fo rm a scab. Animals were 
sacrificed with pentobarbital overdose, and wounds from four animals 
were harvested at 12 h, 1 d, 3 d, 5 d, and 7 d after wounding. An area of 
7 mm in diameter that included the complete epithelial margins was excised 
at each time point. A similar amount of skin from the backs of three non-
wounded diabetic animals was used as a control. Wound tissue was immedi-
ately frozen in liquid nitrogen and stored at -70·C until used for RNA 
isolation. 
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RNA Isolation and RNase Protection Analysis Isolation of total cel-
lular RNA and RNase protection analysis were performed as described [15]. 
Briefly, DNA probes were cloned into the transcripton vector pBluescript 
KS (+) (Strata gene) and linearized. An antisense transcript was synthesized 
in vitro using T3 or T7 RNA polymerase and e 2p) UTP (800 Ci/mmol), 
Amersham). Samples of 50 Ilg of total cellular RNA were hybridized at 
42 ·C overnight with 100,000 cpm of the labeled antisense transcript. Hy-
brids were digested for 40 min at 30·C with RNAses A and Tl. Protected 
fragments were separated on 5% acrylamide/8 M urea gels and analyzed by 
autoradiography. The DNA templates used to generate anti-sense hybrid-
ization probes for aFGF, bFGF, KGF, FGFRl, and FGFR3 were recently 
described [17]. For the detection ofFGFR2 mRNA we used a 271 -bp frag-
ment corresponding to nucleotides 831-1102 of the KGF receptor variant of 
FGFR2 [18]. The increase in FGF mRNA levels was quantitated by laser-
scanning densitometry of the autoradiograms. The same set of RNAs was 
used for the detection of aFGF, bFGF, and KGF mRNA. All experiments 
were repeated once with a different set of RN As from an independent 
wounding experiment. The KGF experiment was repeated twice with 
RNAs from two independent wound-healing experiments. 
RESULTS 
We analyzed the expression of KGF during skin repair in geneti-
cally diabetic db/db mice. The levels ofKGF mRNA during wound 
healing were assessed by RNase protection analysis. mRNA encod-
ing KGF was detected in nonwounded skin of db/db mice (Fig 1) at 
similar levels as in non-diabetic mice (data not shown). As in non-
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Figure 2. Induction of KGF mRNA expression in db/db mice in 
comparison to normal mice. Expression of KGF mRNA during wound 
healing in db/db mice and in healthy control mice was analyzed by RNAse 
protection assay. The increase in KGF mRNA induction in control mice and 
db/db mice was quantitated by laser scanning densitometry of the autoradio-
grams. The degree of induction compared to the basal level is shown as a 
function of time after injury. 0 , diabetic mice; ., control mice. 
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Figure 3. Expression of aFGF and bFGF mRNA during wound healing in db/db mice. Total cellular RNA (50 Ilg) from non-wounded and wounded 
mouse back skin of db/db mice was analyzed by RNAse protection assay using probes that hybridize to mRNA encoding aFGF (A) and bFGF (B) as indicated. 
The expression level in non-wounded skin of control mice is shown for comparison (see very right lanes of A and B). Hybridization was performed under 
high-stringency conditions to avoid cross-hybridization with other FGF mRNAs. The same RNA preparations were used for all hybridizations of Figs 1, 3, 
and 4. Fifty micrograms of tRNA were used as a control. 1000 cpm of the hybridization probes were added to the lanes labeled "probe" and used as a size 
reference. The gels were exposed overnight. 
diabetic mice, there was an induction ofKGF mRNA during wound 
healing in diabetic mice (Fig 1). However, the degree of induction 
was only 5-10-fold compared to 160-fold in normal mice (Fig 2). 
Most importantly, there was a significant delay in KGF induction in 
the diabetic animals, and the maximal levels of KGF expression 
were only obtained between 3 and 5 d after injury (Figs 1 and 2). In 
contrast, expression of KGF mRNA in wounds from non-diabetic 
mice had reached a peak 24 h after injury. This reduced and delayed 
KG F induction in diabetic mice was reproduced in two independent 
experiments (data not shown). These data show that KGF mRNA 
expression is low in diabetic animals during the time when re-epi-
thelialization normally occurs and thus might underlie the delayed 
keratinocyte proliferation seen in wounds of db/db mice [19] . 
In addition to KGF, we also analyzed the expression of aFGF and 
bFGF during wound healing in db/db mice. mRNA encoding these 
mitogens had been found to be induced during wound repair of 
healthy, non-diabetic mice. As shown in Fig 3A,B, both aFGF and 
bFGF mRNA was found in nonwounded skin of db/db mice. 
Whereas bFGF mRNA levels were similar in the non-wounded 
skin of control mice and db/db mice (Fig 3B; compare the lanes 
labeled "normal skin"), diabetic mouse skin had 5 -1 O-fold higher 
levels of aFGF mRNA compared to the skin of normal mice (Fig 
3A; compare the lanes labeled "normal skin"). 
Upon injury, induction of both aFGF and bFGF occurred earlier 
in diabetic mice than in normal mice. bFGF mRNA expression was 
induced 3.5-fold, peaking within 24 h after injury. Expression of 
this mitogen subsequently declined, and bFGF mRNA returned to 
the basal level within 3 d after injury. In contrast, enhanced expres-
sion ofbFGF expression occurred during the first 7 d after injury in 
normal mice, and the peak was only reached at day 5 after injury. In 
db/db mice, as in normal mice, induction ofbFGF mRNA expres-
sion was significantly lower (3.5-fold and 4-fold, respectively) than 
induction ofKGF expression (lO-fold and 160-fold, respectively). 
Due to the high expression level of aFGF mRNA in nonwounded 
skin of db/db mice (five- to tenfold higher levels compared to skin 
of normal mice), the degree of induction of aFGF expression was 
low (less than twofold) in these animals, although the absolute 
expression level of aFGF mRNA was high during the first 24 h after 
injury. Expression of this growth factor declined rapid ly after the 
first day, and extremely low levels of aFGF mRNA were found at 
later stages of wound healing (Fig 3). In contrast, a tenfold induc-
tion of aFGF expression was observed in normal mice, and aFGF 
expression levels remained elevated within the first 3 d after injury. 
In contrast to FGFs, expression of FGF receptors was not in-
creased during wound healing in diabetic mice (Fig 4). Whereas 
FGF receptor mRNA levels were constant during wound healing in 
control mice, expression levels of all FGF receptor mRNAs declined 
(Fig 4). The most significant decline was observed for FGFR2 (Fig 
4, second panel). Because differential splicing in the extracellular 
region ofFGF receptors had been shown to determine ligand bind-
ing specificity [20 -22], we used hybridization probes for FGFR1, 
FGFR2, and FGFR3, which enabled us to distinguish between the 
differe~t splice variants [17] . As shown in Fig 4, upper panel, the 
Ilk splIce vanant of FGFR1, which binds aFGF and bFGF with 
high affinity [20]' was the major FGFRl splice variant in normal 
skin and during wound healing. In contrast, the FGFR1-I1lb splice 
variant, which is primarily a receptor for aFGF [20], was expressed 
at much lower levels. The predominant FGFR3 variant was the 
FGFR3-I1Ib form, which has recently been shown to bind aFGF 
exclusively [22] . In contrast, the FGFR3-II1c variant, which has a 
broader ligand-binding specificity [23], was only detectable after 
longer exposure times (data not shown). In the case of FGFR2, the 
IIIb splice variant, which is a high-affinity receptor for aFGF and 
also for KGF [21], was the most abundant splice variant in wounded 
and nonwounded skin of db/db mice. The FGFR2-IIIc variant, 
which binds aFGF and bFGF but not KGF [21], was expressed at 
much lower levels. Therefore, the FGFR2 receptors, which are 
expressed in wounded and non-wounded skin of db/db mice, pri-
marily represent receptors for KGF and aFGF. The decline of the 
expression level of this receptor might further contribute to the 
delayed wound re-epithelialization in these animals. 
Taken together these data demonstrate that expression of FGFs is 
abnormal during wound healing in db/db mice compared to normal 
mice and suggest that a defect in FGF and/or FGF receptor expres-
sion might be at least partially responsible for the wound-healing 
defects seen in these animals. 
DISCUSSION 
Several members of the fibroblast growth factor family have been 
shown to significantly improve wound healing in animals when 
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Figure 4. mRNA expression ofFGF receptors during wound healing 
in db/db mice. Total cellular RNA (50 Jig) from non-wounded and 
wounded back skin of db/db mice was analyzed by RNase protection assay 
with RNA hybridization probes complementary to mRNA encoding (from 
top to bottom) FGFR1, FGFR2, and FGFR3. The protected fragments that 
are generated by transcripts encoding FGFR1-IIIb and -IIIc, FGFR2-IIIb 
and -ilic as well as FGFR3-IIIb and -lllc are indicated. The same RNA 
preparations were used for all hybridizations of Figs 1, 2, and 4. The time 
after injury is indicated on top of each lane. The mRNA expression ofFGF 
receptors in non-wounded skin of db/db mice is shown in the lanes labeled 
"normal skin." The FGFRl and FGFR2 protection assay gels were exposed 
overnight; the FGFR3 protection assay gel was exposed for 48 h. 
applied exogenously to a wound [3 - 5,24 - 29]. This effect is partic-
ularly obvious in animals with wound-healing defects, such as in 
genetically diabetic db/db mice [3-5], indicating that FGFs them-
selves or other growth factors with similar function may be limiting 
during wound healing of these animals. 
Recently we have demonstrated the induction of expression of 
several FGFs during the process of wound healing [15], particularly 
for KGF, which was 160-fold induced within 24 h after injury . 
Because KGF is a potent growth factor for keratinocytes [12,16], 
this finding suggests that dermally derived KGF acting in a para-
crine fashion stimulates migration and proliferation of epidermal 
keratinocytes seen during wound healing. 
The beneficial effect of exogenous KGF and other FGFs in the 
treatment of problematic wounds suggests that expression or availa-
bility of endogenous FGF is impaired in wound-healing disorders. 
Our data demonstrate that expression ofKGF is indeed reduced and 
delayed in these animals, suggesting that this aberrant expression of 
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KGF might be at least partially responsible for their wound-healing 
defect. Furthermore, expression of aFGF and bFGF is very different 
in db/db mice compared to normal mice. Induction of both mito-
gens is earlier in diabetic mice compared to normal mice, and ex-
pression of both growth factors had already returned to basal levels 
within 3 d after injury. Thus, there seems to be a deficiency in the 
levels of various FGFs during the period when re-epithelialization, 
granulation tissue formation, and matrix deposition normally occur 
[1]. Furthermore, we also found a decline in FGF receptor levels 
during wound healing in db/ db mice, which might further contrib-
ute to the delayed wound repair in these animals. 
The reason for the aberrant expression of FGFs during wound 
healing of db/db mice is presently unclear. The delayed infiltration 
of acute inflammatory cells into the wound space might be respon-
sible, because of the lack of cytokines released from these cells 
which regulate FGF expression. Specifically, db/db mouse macro-
phages, considered a key regulatory cell in repair (for review see 
[30]), might have an impaired ability to synthesize either FGFs 
directly or inducers ofFGF expression. This hypothesis is supported 
by our recent finding that macrophage-derived cytokines can sig-
nificantly induce KGF expression ill vitro [31] . Alternatively, there 
might be different levels of blood components in db/db mice that 
are responsible for FGF gene regulation and that become available 
for the target cells upon hemorrhage at the wound site. This hy-
pothesis is supported by our recent finding that total serum as well as 
platelet-poor plasma serum are potent inducers of KGF expression 
in quiescent cultured human fibroblasts [31]. This suggests the pres-
ence of one or more serum components that induce KGF expression 
ill vivo. Thus, a reduced level of these factors in the serum of 
db/db mice might at least partially underlie the aberrant ex pres-
si~n of KGF and possibly other FGFs during tissue repair in db/db 
mIce. 
We are tempted to speculate that aberrant expression of FGF 
might be at least partially responsible for the wound-healing defects 
seen in these animals and possibly also in human diabetes. Finally, 
our data provide a possible explanation for the beneficial effect of 
exogenous FGF in the treatment of poorly healing wounds. The 
knowledge ofFGF expression in normal and defective wound heal-
ing might help to improve the use ofFGF in the treatment of these 
wounds by choice of the most suitable type ofFGF and the timing of 
its application. 
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